Wegovy is FDA-approved for weight loss and cardiovascular risk reduction, while Rybelsus, like Ozempic, is approved for Type 2 diabetes
Its primary pharmacological characterization was published in European Journal of Endocrinology (PMID 9849822), where the authors identified it as the first growth-hormone-secretagogue receptor (GHSR-1a) agonist achieving GH-release selectivity comparable to GHRH in animal models
CJC 1295 stimulates growth hormone production in the pituitary gland
Peptides are short chains of amino acids, the building blocks of proteins, which play a crucial role in various bodily functions, including muscle growth and repair
The contraindications are due to health concerns
And your liver gets overloaded and damaged, making it unable to do its job of detoxification